S A Vora

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma
    S A Vora
    Department of Radiation Oncology, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
    Cancer 89:1946-52. 2000
  2. ncbi Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer
    Sujay A Vora
    Department of Radiation Oncology, Mayo Clinic Scottsdale, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 68:1053-8. 2007
  3. ncbi Role of radiation therapy for facial skin cancers
    Sujay A Vora
    Department of Radiation Oncology, Mayo Clinic Scottsdale, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
    Clin Plast Surg 31:33-8. 2004
  4. ncbi Prostate brachytherapy seed embolization to the right renal artery
    Ba D Nguyen
    Department of Radiology, Mayo Clinic, Scottsdale, AZ, USA
    Brachytherapy 8:309-12. 2009
  5. ncbi The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer
    Steven E Schild
    Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 62:1432-7. 2005
  6. ncbi Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy
    David J Schwartz
    Department of Radiation Oncology, Mayo Clinic Scottsdale, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 61:60-3. 2005
  7. ncbi Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer
    William W Wong
    Department of Radiation Oncology, Mayo Clinic Scottsdale, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 60:24-9. 2004
  8. ncbi Treatment planning for dose escalation in non-small cell lung cancer (NSCLC)
    Steven E Schild
    Department of Radiation Oncology Mayo Clinic, Scottsdale, AZ, USA
    Med Dosim 29:196-203. 2004
  9. ncbi Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer
    Steven E Schild
    Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 54:729-34. 2002
  10. ncbi Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy
    Christopher F Serago
    Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL 32224, USA
    Int J Radiat Oncol Biol Phys 53:1130-8. 2002

Detail Information

Publications15

  1. ncbi High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma
    S A Vora
    Department of Radiation Oncology, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
    Cancer 89:1946-52. 2000
    ....
  2. ncbi Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer
    Sujay A Vora
    Department of Radiation Oncology, Mayo Clinic Scottsdale, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 68:1053-8. 2007
    ....
  3. ncbi Role of radiation therapy for facial skin cancers
    Sujay A Vora
    Department of Radiation Oncology, Mayo Clinic Scottsdale, 13400 E Shea Blvd, Scottsdale, AZ 85259, USA
    Clin Plast Surg 31:33-8. 2004
    ..We advocate the discussion of this treatment modality with every such patient, even if the treating physician does not recommend it. Only then can a patient provide genuine "informed consent" for treatment...
  4. ncbi Prostate brachytherapy seed embolization to the right renal artery
    Ba D Nguyen
    Department of Radiology, Mayo Clinic, Scottsdale, AZ, USA
    Brachytherapy 8:309-12. 2009
    ..We report three cases of seed embolization to the right renal artery after iodine-125 (I-125) transperineal interstitial permanent prostate brachytherapy...
  5. ncbi The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer
    Steven E Schild
    Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 62:1432-7. 2005
    ..This analysis was performed to determine the long-term results of a Phase I trial that included 3-times-a-day radiotherapy (TIDRT) and concurrent daily cisplatin (CDDP) for Stage III non-small-cell lung cancer...
  6. ncbi Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy
    David J Schwartz
    Department of Radiation Oncology, Mayo Clinic Scottsdale, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 61:60-3. 2005
    ..These findings may aid in better patient selection and therapeutic decisions. Additionally, this information may provide a clearer understanding of the urinary side effects of TIBBP...
  7. ncbi Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer
    William W Wong
    Department of Radiation Oncology, Mayo Clinic Scottsdale, 13400 E Shea Boulevard, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 60:24-9. 2004
    ..Our goal was to investigate the value of these factors in predicting biochemical control (bNED) after EBRT...
  8. ncbi Treatment planning for dose escalation in non-small cell lung cancer (NSCLC)
    Steven E Schild
    Department of Radiation Oncology Mayo Clinic, Scottsdale, AZ, USA
    Med Dosim 29:196-203. 2004
    ..It is possible that the use of noncoplanar fields or intensity-modulated radiation therapy (IMRT) may further improve the therapeutic ratio...
  9. ncbi Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer
    Steven E Schild
    Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 54:729-34. 2002
    ..To determine the maximal tolerated dose of daily cisplatin (CDDP) administered during an aggressive program of hyperfractionated accelerated radiotherapy (t.i.d. RT) for locally advanced non-small-cell lung cancer (NSCLC)...
  10. ncbi Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy
    Christopher F Serago
    Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL 32224, USA
    Int J Radiat Oncol Biol Phys 53:1130-8. 2002
    ....
  11. ncbi Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy
    William W Wong
    Department of Radiation Oncology, Mayo Clinic Arizona, Scottsdale, Arizona 85259, USA
    Cancer 115:5596-606. 2009
    ....
  12. ncbi Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy
    O Kenneth Macdonald
    Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Int J Radiat Oncol Biol Phys 58:1530-5. 2004
    ..A consensus on a definition of biochemical disease-free survival after salvage RT is critical for meaningful comparison of the available data and to future progress in treating this disease process...
  13. ncbi Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy
    O Kenneth Macdonald
    Department of Radiation Oncology, Section of Urology, Mayo Clinic Scottsdale, 13400 E. Shea Boulevard, Scottsdale, AZ 85259, USA
    J Urol 170:1833-7. 2003
    ..CONCLUSIONS: Optimal benefit from salvage RT was achieved in patients with a PSA less than 0.6 ng/ml and doses of RT greater than 64.8 Gy. Early treatment with a sufficiently high dose of RT maximizes the potential for salvage...
  14. ncbi Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer
    Michele Y Halyard
    Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona 85259, USA
    Am J Clin Oncol 27:389-94. 2004
    ..quot; We conclude that TRAM flaps can be irradiated with few complications and acceptable cosmetic results...
  15. ncbi Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4)
    Michele Y Halyard
    Mayo Clinic, Scottsdale, AZ, USA
    Int J Radiat Oncol Biol Phys 67:1318-22. 2007
    ..This multi-institutional, double-blind, placebo-controlled trial was conducted to provide definitive evidence of this mineral's palliative efficacy...